ReviewNeuroprotection (Chichester, England)2026
Chronic high-altitude exposure and intracerebral hemorrhage: A novel perspective from the vascular-immune-neuronal network.
Review in Neuroprotection (Chichester, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intracerebral hemorrhage (ICH) under chronic high-altitude exposure exhibits distinct epidemiological characteristics: higher incidence, younger age at onset, more severe perihematomal edema, and worse clinical outcomes. However, the specific mechanisms underlying its pathogenesis and progression remain incompletely understood. In this review, we demonstrate that immigrant populations subjected to chronic high-altitude exposure are at increased risk of ICH relative to indigenous populations (Tibetans, Andeans), primarily due to the lack of adaptive genetic variations such as endothelial PAS domain protein 1 and small ubiquitin-like modifier-specific peptidase 1. Additionally, high-altitude polycythemia, high-altitude hypertension, and hyperuricemia have been identified as critical risk factors for high-altitude ICH. Further mechanistic exploration reveals that chronic high-altitude exposure-induced brain injury is structurally underpinned by vascular-immune-neuronal network dysfunction, which entails the interactive crosstalk of "vascular injury-immune infiltration-neurodegeneration" and thereby creates a unique pathological niche for high-altitude ICH. At the molecular level, the core driving mechanism is the reciprocal activation of the hypoxia-inducible factor pathway, oxidative stress, and neuroinflammation. This review represents a comprehensive synthesis of chronic high-altitude exposure-related brain injury and the subsequent exacerbation of ICH, providing a valuable reference for future research on high-altitude encephalopathy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.